This is a phase I study to assess the safety and feasibility of IL-8 receptor modified patient-derived activated CD70 CAR T cell therapy in CD70+ adult glioblastoma
- Investigator
- Ashley Ghiaseddin
- Ages
- 18 Years - 80 Years
- Sexes
- All
Clinical trials
BOB体育 provides leading-edge blood cancer and solid tumor treatments.
Make an appointment
(352) 733-0972
Find a clinical trial
-
IMPACT; Phase I Study of IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult GBM -
CardiAMP This is a prospective, multi-center, randomized, controlled, patient* and evaluator-blinded study comparing treatment with the CardiAMP cell therapy to a sham control treatment. A roll-in phase with a maximum of 10 subjects may occur.
- Investigator
- R. David Anderson
- Ages
- 21 Years - 90 Years
- Sexes
- All